Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
May 10, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 10, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 22, 2021 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 22, 2021 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
April 1, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
April 1, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
April 1, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
April 1, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
April 1, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
April 1, 2021 4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us